Transfer learning of an in vivo- derived senescence signature identifies conserved and tissue-specific senescence across species and diverse pathologies
Authors:
- Christopher CherryCCChristopher Cherry
- James I AndorkoJAJames I Andorko
- Kavita KrishnanKKKavita Krishnan
- Joscelyn C MejiasJMJoscelyn C Mejias
- Helen Hieu NguyenHNHelen Hieu Nguyen
- Katlin B StiversKSKatlin B Stivers
- Elise F Gray-GaillardEGElise F Gray-Gaillard
- Anna RutaARAnna Ruta
- Ines SturmlechnerISInes Sturmlechner
Preprint
Abstract
Senescent cells (SnCs) contribute to normal tissue development and repair but accumulate with aging where they are implicated in a number of pathologies and diseases. Despite their pathological role and therapeutic interest, SnC phenotype and function in vivo remains unclear due to the challenges in identifying and isolating these rare cells. Here, we developed an in vivo -derived senescence gene expression signature using a model of the foreign body response (FBR) fibrosis in a p16 Ink4a - reporter mouse, a cell cycle inhibitor commonly used to identify SnCs. We identified stromal cells (CD45 - CD31 - CD29 + ) as the primary p16 Ink4a expressing cell type in the FBR and collected the cells to produce a SnC transcriptomic signature with bulk RNA sequencing. To computationally identify SnCs in bulk and single-cell data sets across species and tissues, we used this signature with transfer learning to generate a SnC signature score (SenSig). We found senescent pericyte and cartilage-like fibroblasts in newly collected single cell RNAseq (scRNASeq) data sets of murine and human FBR suggesting populations associated with angiogenesis and secretion of fibrotic extracellular matrix, respectively. Application of the senescence signature to human scRNAseq data sets from idiopathic pulmonary fibrosis (IPF) and the basal cell carcinoma microenvironment identified both conserved and tissue-specific SnC phenotypes, including epithelial-derived basaloid and endothelial cells. In a wound healing model, ligand-receptor signaling prediction identified putative interactions between SnC SASP and myeloid cells that were validated by immunofluorescent staining and in vitro coculture of SnCs and macrophages. Collectively, we have found that our SenSig transfer learning strategy from an in vivo signature outperforms in vitro -derived signatures and identifies conserved and tissue-specific SnCs and their SASP, independent of p16 Ink4a expression, and may be broadly applied to elucidate SnC identity and function in vivo .Keywords
This publication has 72 references indexed in Scilit:
- Cellular senescence and the senescent secretory phenotype: therapeutic opportunitiesJournal of Clinical Investigation, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- RNAscopeThe Journal of Molecular Diagnostics, 2012
- Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targetsNature Reviews Drug Discovery, 2011
- A Wound Size–Dependent Effect of Myeloid Cell–Derived Vascular Endothelial Growth Factor on Wound HealingJournal of Investigative Dermatology, 2011
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- A first-generation microsatellite-based genetic linkage map of the Siberian jay (Perisoreus infaustus): insights into avian genome evolutionBMC Genomics, 2009
- Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor SuppressorPLOS Biology, 2008
- Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiencyNature Cell Biology, 2008